Evidence map›Paper›PMID 34551012›Full record

ArticlePloS one2021

Measles antibody seropositivity among children with allergic diseases: A cross-sectional study in the Japan Environment & Children's Pilot Study.

Mayako Saito-Abe, Kiwako Yamamoto-Hanada, Kensuke Shoji, Miori Sato, Makoto Irahara, Yu Taniguchi, Makiko Sekiyama, Nathan Mise, Akihiko Ikegami, Masayuki Shimono and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Mayako Saito-AbeMedical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.ORCID 0000-0002-8845-7034
Kiwako Yamamoto-HanadaMedical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.
Kensuke ShojiDivision of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
Miori SatoMedical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.
Makoto IraharaMedical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.
Yu TaniguchiJapan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Ibaraki, Japan.
Makiko SekiyamaJapan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Ibaraki, Japan.
Nathan MiseDepartment of Environmental and Preventive Medicine, Jichi Medical University, Tochigi, Japan.ORCID 0000-0001-8334-1123
Akihiko IkegamiDepartment of Environmental and Preventive Medicine, Jichi Medical University, Tochigi, Japan.
Masayuki ShimonoRegional Center for Pilot Study of Japan Environment and Children's Study, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.ORCID 0000-0001-7435-6593
Reiko SugaRegional Center for Pilot Study of Japan Environment and Children's Study, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Masafumi SanefujiResearch Center for Environment and Developmental Medical Sciences, Kyushu University, Fukuoka, Japan.
Shouichi OhgaResearch Center for Environment and Developmental Medical Sciences, Kyushu University, Fukuoka, Japan.
Masako OdaDepartment of Public Health, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Hiroshi MitsubuchiDepartment of Neonatology, Kumamoto University Hospital, Kumamoto, Japan.
Isao MiyairiDivision of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
Yukihiro OhyaMedical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan.
National Center For Child Health and Development · JPJichi Medical University · JPKyushu University · JPNational Institute for Environmental Studies · JPUniversity of Occupational and Environmental Health Japan · JPKumamoto Health Science University · JPKumamoto University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe relationship between allergic individuals and their responsiveness to routine vaccines has rarely been investigated. This study examined whether the seroprevalence of measles antibody differed between children with and without allergic diseases in the general pediatric population.

methodsThe cross-sectional study was performed within a prospective general birth cohort (a pilot study of the Japan Environment & Children's Pilot Study [JECS]) of children aged 8 years. The clinical history of allergic diseases, measles, and the concentration of measles immunoglobulin G titers in serum enzyme immunoassay were examined. Fisher's exact tests were used to assess the relationships between the allergic characteristics of the children and their measles antibody positivity rates.

resultsThis study included 162 children. Any allergic disease was reported in 75 (46.3%). The measles antibody positivity rate was 94.7% among children with any allergic diseases and 92.0% among children without allergic diseases. Our results revealed no differences in measles antibody seropositivity between children with allergies and controls.

conclusionsChildren with allergies mount and maintain a comparable immune response to the measles vaccine.

Indexed as

Antibodies, ViralHypersensitivityMeaslesChildCross-Sectional StudiesFemaleHumansImmunoglobulin GJapanMaleMeasles VaccineMeasles virusPilot ProjectsProspective StudiesSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin GMeasles Vaccine

Identifiers

PMID34551012
PMCPMC8457502
OpenAlexW3200071041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.